Predictive value of soluble suppression of tumourigenicity 2 on myocardial reperfusion
Authors:
- 30 September 2019
- journal article
- research article
- Published by Wiley in Internal Medicine Journal
- Vol. 50 (8) , 985-992
Abstract
Background: High baseline level of soluble suppression of tumourigenicity 2 (sST2) was an independent predictor of cardiovascular death and heart failure in ST‐segment elevation myocardial infarction (STEMI).Aims: To investigate the value of serum sST2 baseline levels in predicting myocardial reperfusion in patients with STEMI undergoing primary percutaneous coronary intervention (PPCI).Methods: Consecutive STEMI patients who underwent PPCI within 12 h after the onset of chest pain were enrolled, and were divided into Thrombolysis In Myocardial Infarction (TIMI) myocardial perfusion grading (TMPG) 0/1/2 group and TMPG 3 group based on post‐procedural TMPG. Baseline clinical characteristics, lesions and procedural characteristics were compared. Univariate logistic regression and multivariate linear logistic analysis were performed to identify independent predictors of impaired myocardial reperfusion (TMPG 0/1/2). Receiver‐operating characteristics curve (ROC) analysis of sST2 was performed to identify the optimum cut‐off value for predicting the myocardial reperfusion.Results: A total of 121 patients was enrolled in this study. Univariate logistic regression analysis showed that Killip II–III, high levels of sST2 and brain natriuretic peptide were risk factors of TMPG 0/1/2. Multivariable logistic regression analysis revealed that sST2 was an independent predictor of impaired myocardial reperfusion (odds ratio 12.318, 95% confidence interval 4.567–33.220, P < 0.001). ROC curve analysis showed that the area under curve of sST2 was 0.849, and the best cut‐off value was 2.003 ng/mL, with a sensitivity of 89.2% and a specificity of 67.9%.Conclusion: The elevated levels of sST2 on admission were associated with impaired myocardial reperfusion in STEMI patients undergoing PPCI.Keywords
This publication has 33 references indexed in Scilit:
- Soluble ST2 for Prediction of Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Receiving Primary PCIInternational Heart Journal, 2019
- Incidence and predictors of microvascular dysfunction assessed by the index of microcirculatory resistance following primary PCI for ST-elevation myocardial infarctionInternational Journal of Cardiology, 2011
- ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cellsMolecular and Cellular Biochemistry, 2009
- Nonmyocardial Production of ST2 Protein in Human Hypertrophy and Failure Is Related to Diastolic LoadJACC, 2008
- Complementary Roles for Biomarkers of Biomechanical Strain ST2 and N-Terminal Prohormone B-Type Natriuretic Peptide in Patients With ST-Elevation Myocardial InfarctionCirculation, 2008
- Predictive Value of the Index of Microcirculatory Resistance in Patients With ST-Segment Elevation Myocardial InfarctionJACC, 2008
- Clinical and Procedural Predictors of No-Reflow Phenomenon After Primary Percutaneous Coronary Interventions Experience at a Single CenterCirculation Journal, 2008
- Expression and Regulation of ST2, an Interleukin-1 Receptor Family Member, in Cardiomyocytes and Myocardial InfarctionCirculation, 2002
- The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defenceBiochemical Society Transactions, 2000
- Different promoter usage and multiple transcription initiation sites of the interleukin‐1 receptor‐related human ST2 gene in UT‐7 and TM12 cellsEuropean Journal of Biochemistry, 1999